Letter on «(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial».

Icon for BioMed Central Related Articles

Letter on "(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial".

Crit Care. 2021 02 09;25(1):55

Authors: Kritikos A, Lamoth F

PMID: 33563306 [PubMed - in process]